Cargando…
Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma
Autores principales: | Ravanetti, Lara, Dekker, Tamara, Guo, Lihui, Dijkhuis, Annemiek, Dierdorp, Barbara S., Diamant, Zuzana, Florquin, Sandrine, Lutter, René |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087922/ https://www.ncbi.nlm.nih.gov/pubmed/36094742 http://dx.doi.org/10.1111/all.15513 |
Ejemplares similares
-
Influenza exacerbations in an acute and chronic house dust mite ‘asthma’ model
por: Bal, Suzanne M, et al.
Publicado: (2013) -
Imprinting of bronchial epithelial cells upon in vivo rhinovirus infection in people with asthma
por: Ravi, Abilash, et al.
Publicado: (2022) -
Eosinophils capture viruses, a capacity that is defective in asthma
por: Sabogal Piñeros, Yanaika S., et al.
Publicado: (2019) -
Regulation of Progranulin Expression in Human Microglia and Proteolysis of Progranulin by Matrix Metalloproteinase-12 (MMP-12)
por: Suh, Hyeon-Sook, et al.
Publicado: (2012) -
Haemonchus contortus: siRNA mediated knockdown of matrix metalloproteinase 12A (MMP-12) results in reduction of infectivity
por: Naqvi, Muhammad Ali-ul-Husnain, et al.
Publicado: (2020)